The abstract is read at the publisher; the summary is JClub's.
In a hospital-based sample of 101 women in Abuja, Nigeria, hrHPV DNA detection rose from 30.5% with NILM to 81.8% with invasive cervical cancer.
- Why it matters: Nigeria lacks data on hrHPV prevalence across the full cervical disease spectrum, limiting evidence for HPV-based screening and genotype surveillance in Abuja.
- What they did: Cervical specimens from 59 NILM and 42 lesion cases (23 LSIL, 8 HSIL, 11 invasive cancers) were tested with the Atila ScreenFire assay reporting four pooled hrHPV target groups.
- The result: hrHPV was detected in 37/101 women (36.6%), with invasive cancer linked to higher odds versus NILM (unadjusted OR 10.25; age-adjusted OR 9.90), and non-16/18 target groups detected substantially.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.